TOKYO] Strategists at Goldman Sachs cut their targets for key Chinese stock indexes for a second time this month, citing ...

The hitch in decision making has caused a growing backlog of deals at Goldman Sachs, he said ... trading during the market swings around DeepSeek's impact on Nvidia Corp. (NVDA) as well as ...

A potential U.S. launch of this Chinese biotech's new lung cancer drug - which bested Merck's blockbuster Keytruda - is a key ...

Strategists at Goldman Sachs cut their targets for key Chinese stock indexes for a second time this month, citing heightened trade tensions with the US.